Progress in the pathogenesis of thyroid-associated ophthalmopathy and new drug development
Thyroid-associated ophthalmopathy (TAO) is the most common extrathyroidal manifestation of toxic diffuse goiter (Graves' disease), also known as Graves' ophthalmopathy/orbitopathy. As an organ-specific autoimmune disease, the pathogenesis of TAO is still unclear. In recent years, great pro...
Main Authors: | Yazhuo Huang, Sijie Fang, Shuo Zhang, Huifang Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Taiwan Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.e-tjo.org/article.asp?issn=2211-5056;year=2020;volume=10;issue=3;spage=174;epage=180;aulast=Huang |
Similar Items
-
Presence of thyroid-associated ophthalmopathy in Hashimoto’s thyroiditis
by: Emrah Kan, et al.
Published: (2014-08-01) -
Observation of curative effect of methylprednisolone with octreotide retrobulbar injection therapy on thyroid associated ophthalmopathy
by: Xi-Feng Peng, et al.
Published: (2014-10-01) -
Research progress of radiotherapy for thyroid-associated ophthalmopathy
by: Xiao-Shu Tang, et al.
Published: (2022-07-01) -
Effect of abnormal adipose tissue proliferation in thyroid-associated ophthalmopathy
by: Wei Liu, et al.
Published: (2019-11-01) -
The role of autophagy in thyroid-related ophthalmopathy
by: Shan-Si Yuan, et al.
Published: (2021-02-01)